Portfolio Companies

Paris, France, October 22 2020, 6.30 am CEST The following information is not intended for, and may not be accessed by, or distributed or disseminated to, persons resident or ph...
Read more

Proceeds to Support Ongoing Clinical Development of InRhythm™, A First-of-its-Kind Inhaled Antiarrhythmic for Treatment of Paroxysmal Atrial Fibrillation (PAF) Positive Phase 2...
Read more

Lund, Sweden, 15:00 CET, 19 October 2020 – BONESUPPORT™, an emerging leader in orthobiologics for the management of bone injuries, announces that the company, through a 510 (...
Read more

STOCKHOLM — October 19, 2020 — Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO) today announces that the Company has submitted an Investigational New Drug (IND) applicatio...
Read more

Paris, France, October 15, 2020, 7:30 am CEST – GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commerc...
Read more

UPPSALA, SWEDEN, AND NEW YORK, NY, USA, October 15th, 2020: Orexo, a Swedish pharmaceutical company focused on improved pharmaceuticals and digital therapies, and Lyfebulb, a pati...
Read more

BOSTON, Oct. 14, 2020 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE), a biopharmaceutical company focused on developing and commercializing novel cancer therapeut...
Read more

Paris, France, October 14, 2020, 7:30 am CEST – GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commerc...
Read more

    For more information, please see Targovax ASA – successfully completed private placement             ...
Read more

SAN FRANCISCO--(BUSINESS WIRE)--Oct. 14, 2020-- Spruce Biosciences, Inc., a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare ...
Read more